The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
第一作者:
Natividad,Garrido-Mesa
第一单位:
Centro de Investigaciones Biomédicas en Red - Enfermedades Hepáticas y Digestivas, Department of Pharmacology, Center for Biomedical Research, University of Granada, Granada, Spain. ngarrido@ugr.es
作者:
主题词
动物(Animals);抗菌药(Anti-Bacterial Agents);结肠炎(Colitis);结肠(Colon);细胞因子类(Cytokines);硫酸葡聚糖(Dextran Sulfate);疾病模型, 动物(Disease Models, Animal);药物疗法, 联合(Drug Therapy, Combination);大肠杆菌(Escherichia coli);女(雌)性(Female);基因表达调控(Gene Expression Regulation);炎症(Inflammation);基质金属蛋白酶9(Matrix Metalloproteinase 9);膜蛋白质类(Membrane Proteins);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);米诺环素(Minocycline);黏蛋白3(Mucin-3);一氧化氮合酶Ⅱ型(Nitric Oxide Synthase Type II);磷蛋白类(Phosphoproteins);有益菌种(Probiotics)
DOI
10.1016/j.bcp.2011.09.004
PMID
21930116
发布时间
2016-11-25
- 浏览29

Biochemical pharmacology
1891-900页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文